Original article
The relationship between glycemic control and platelet activity in type 2 diabetes mellitus

https://doi.org/10.1016/j.jdiacomp.2008.01.006Get rights and content

Abstract

Aims

Platelet activity and aggregation potential, which are essential components of thrombogenesis and atherosclerosis, can be conveniently estimated by measuring mean platelet volume (MPV) as part of whole blood count. It has been shown that MPV was significantly higher in diabetes mellitus (DM); however, the effect of glycemic control on MPV has not been studied. The aim of this study was to investigate the relationship among MPV, glycemic control, and micro- and macrovascular complications in type 2 DM.

Methods

Seventy patients with type 2 DM and 40 age- and sex-matched healthy individuals were enrolled. Diabetic patients were grouped into those with glycated hemoglobin (HbA1c) levels ≤7% (Group A, n=35 patients) and those with HbA1c >7% (Group B, n=35 patients). Initially, both groups were compared with regard to MPV, HbA1c, serum lipid levels, coronary artery disease, retinopathy, neuropathy, and nephropathy. Thereafter, Group B was called to monthly visits to obtain improved control glycemic control, which was defined as achievement of HbA1c ≤7%. At the end of 3 months of follow-up, Group B was reevaluated.

Results

MPV was significantly higher in patients with DM than in controls (8.7±0.8 fl vs. 8.2±0.7 fl, P=.002). In diabetic patients, there was a significant positive correlation between MPV and HbA1c levels (r=.39, P=.001) but not diabetic vascular complications. When we compared the two diabetic groups, Group B patients had significantly higher MPV than Group A (9.0±0.7 fl vs. 8.4±0.8 fl, P=.01). Thirty patients (86%) of Group B achieved improved glycemic control at the end of the 3 months. MPV of the patients with improved glycemic control were significantly decreased compared to baseline MPV (8.4±0.8 fl vs. 9.0±0.7 fl, P=.003).

Conclusions

Our results suggested a close relationship between poor glycemic control and increased platelet activity in patients with type 2 DM. Furthermore, platelet activity recovered through improved glycemic control, which may prevent the possible role of platelets in cardiovascular events in these patients.

Introduction

Type 2 diabetes mellitus (DM) is characterized mainly by tissue insulin resistance and impaired insulin secretion. Increased platelet activity due to abnormal insulin action is emphasized in the development of vascular complications of this disease (Vinik, Erbas, Park, Nolan, & Pittneger, 2001). Platelet activity and aggregation potential, which are essential in atherogenesis and thrombogenesis, can be easily estimated by measuring mean platelet volume (MPV) as part of whole blood count (Bancroft et al., 2000, Bath & Butterworth, 1996, Sharpe & Trinick, 1993, Thompson & Jakubowski, 1983). Large platelets are more active than smaller platelets and produce more prothrombotic factors such as thromboxane A2. This indicates that changes in the platelet count and MPV reflect the state of thrombogenesis (Bath & Butterworth, 1996, Bancroft et al., 2000, Thompson & Jakubowski, 1983). It has been reported that the increase of MPV in the late phase of myocardial infarction is an independent predictor for recurrent myocardial infarction (Hendra, Oswald, & Yudkin, 1988).

Previous studies demonstrated that poor glycemic control was associated with increased diabetic micro- and macrovascular complications (Stettler et al., 2006). It has been shown that MPV was significantly higher in diabetic populations (Sharpe & Trinick, 1993, Tschope et al., 1989, Winocour, 1994); however, the influence of glycemic control on MPV has not been investigated. Starting out from this point, we hypothesized that the increased risk of diabetic vascular complications in patients with poor glycemic control may be related to impaired platelet function and activity, which may be recovered by tight glycemic control. Therefore, the aim of this study was to assess not only the association among MPV, glycemic control, and diabetic vascular complications but also the influence of improved glycemic control on MPV in type 2 diabetic patients.

Section snippets

Patients and methods

A total of 70 type 2 diabetic patients (56 females and 14 males; age, 55.1±10.2 years; range, 32–78 years) were enrolled. The mean (±S.D.) duration of diabetes was 5.9±4.8 years. Diabetic patients were evaluated for metabolic regulation of diabetes, nephropathy, retinopathy, neuropathy, and coronary artery disease (CAD). Twenty (29%) patients had known proliferative diabetic retinopathy treated by photocoagulation, 22 (7.58%) of them had microalbuminuria, 24 (34%) had polyneuropathy, and 9

Results

When we compared 70 patients with type 2 DM and 40 healthy controls, MPV levels were significantly higher in patients with diabetes (8.7±0.8 fl vs. 8.2±0.7 fl, P=.002). There was no statistical difference between the two groups with regard to BMI, age, sex, diastolic BP, creatinine, creatine clearance, platelet count, and platelet mass. Patients with diabetes had a higher systolic BP, total cholesterol, LDL-C, HDL-C, triglycerides, albuminuria, and fasting blood glucose. We found a significant

Discussion

Our study has several important findings. MPV, a marker of platelet function and activation, was significantly higher in patients with type 2 diabetes than in controls. We also found that platelet activity was significantly higher in patients with HbA1c levels >7% than in patients with HbA1c levels ≤7%. Another important finding is that MPV was significantly decreased in patients with poor glycemic control after achieving improved glycemic control. Previous studies have shown that MPV increased

References (29)

  • P.M.W Bath et al.

    Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis

    Clinical Science

    (1994)
  • R.L. Bick

    Platelet function defects: A clinical review

    Seminars in Thrombosis and Hemostasis

    (1992)
  • T. Ceyhan et al.

    The effect of pre-eclampsia on complete blood count, platelet count and mean platelet volume

    Annals of Hematology

    (2006)
  • D. Cox

    Methods for monitoring platelet function

    American Heart Journal

    (1998)
  • Cited by (140)

    • Relationships between diabetes-related vascular risk factors and neurodegeneration biomarkers in healthy aging and Alzheimer's disease

      2022, Neurobiology of Aging
      Citation Excerpt :

      Several studies have shown that increased glycemia levels contribute to increased platelet activity in non-diabetic and diabetic individuals (Kaur et al., 2018; Keating et al., 2003; Shilpi & Potekar, 2018; Zaccardi et al., 2017). Increased platelet activity in diabetic individuals is involved in the development of vascular complications and higher cardiovascular risk (Chen et al., 2017; Demirtunc et al., 2009). This increased platelet activity has been also largely described as an important vascular risk factor involved in AD progression (Liang et al., 2014; Wang et al., 2013; Wu et al., 2021; Yesil et al., 2012).

    View all citing articles on Scopus
    View full text